Stocktwits: MRNA stock clocks best day in over two months on hantavirus vaccine research

Moderna shares surged 12% Friday after Bloomberg reported the company is developing mRNA hantavirus vaccines via U.S. Army Medical Research Institute and Korea University collaborations. Research predates the MV Hondius outbreak; no hantavirus vaccine exists globally.

Cases

—

Deaths

—

Author

Stocktwits

Disease

hantavirus